Advice for people with MS - updated on 21 March
When we come together, we can find answers, quickly, to global MS challenges.
What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?
Discover how MS organisations collaborate to translate vital MS information.
Six months into the COVID-19 Response Initiative
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.
MSIF grants over £500,000 to MS organisations to help them through the pandemic.
Could a vaccine treat MS?
A look back at what the global MS movement has achieved during the pandemic.
The COVID-19 pandemic has brought unprecedented challenges to MS organisations across the world, and the Associação Brasileira de Esclerose Múltipla (ABEM) in Brazil is no exception.
Updated global advice for people with MS and the data behind it
Register now: a webinar for people with MS and MS organisations – your questions answered on the COVID-19 & MS global data sharing initiative
Sharing data to find answers quicker during COVID-19
A message from the CEO of the MS International Federation as the global MS community faces the challenges of the coronavirus